A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma

NCT04324840 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

184

Enrollment

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Glioblastoma

Interventions

DRUG: CC-90010
DRUG: Temozolomide
RADIATION: Radiotherapy

Sponsor

Celgene